What problem do fewer than 100 people diagnosed with tracheal cancer typically face annually?

The problem that fewer than 100 people diagnosed with tracheal cancer typically face annually is primarily related to their survival likelihood. Tracheal cancer is an extremely rare form of cancer, and the limited number of cases means that there is not as much research, funding, or clinical study focused specifically on developing effective treatments for it. Consequently, individuals diagnosed with tracheal cancer may struggle with poorer survival rates compared to more common cancers, due to a lack of targeted therapies and options that adequately address their specific condition.

The rarity of the disease also contributes to challenges in gathering enough clinical data to establish effective treatment regimens, leading to uncertainty in outcomes for patients. Ensuring that individuals receive the most effective care possible with a condition so little understood remains a significant concern.